infl ammatory drugs (NSAIDs) has consistently been associ-ated with a reduced risk of colon cancer. Recent epidemiologic studies have suggested that the use of NSAIDs, particularly aspirin, may also be associated with a reduced risk of prostate cancer, but the evidence remains limited. Methods: We examined the association between NSAID use and pros-tate cancer incidence among 70 144 men in the American Cancer Society’s Cancer Prevention Study II Nutrition Cohort. Information on NSAID use was obtained from a questionnaire completed at study enrollment in 1992 – 1993 and was updated using follow-up questionnaires in 1997 and 1999. We calculated rate ratios (RRs) and 95 % confi-dence intervals (CIs) for prostate cancer incidence associ-ated wi...
Objective. To examine the association between daily use of nonsteroidal anti-inflammatory drugs (NSA...
Objectives: Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are potential candidate...
Epidemiologic studies of statin use in relation to prostate cancer risk have been inconclusive. Rece...
Background: There is substantial evidence that use of NSAIDs reduces the risk of colorectal cancer, ...
Background: Epidemiological evidences regarding the association between the use of non-steroidal ant...
International audienceChronic inflammation may play a role in prostate cancer carcinogenesis. In tha...
Despite strong laboratory evidence that non-steroidal anti-inflammatory drugs (NSAIDs) could prevent...
Background: Despite strong laboratory evidence that non-steroidal anti-inflammatory drugs (NSAIDs) c...
Background: Laboratory and epidemiologic studies suggest that aspirin and nonaspirin nonsteroidal an...
Evidence from laboratory studies suggests that chronic inflammation plays an important role in prost...
BackgroundAlthough most epidemiological studies suggest that non-steroidal anti-inflammatory drug us...
The potentially protective effect of nonsteroidal antiinflammatory drugs (NSAIDs) on prostate cancer...
Background: Randomized trial evidence shows that nonsteroidal anti-inflammatory drug (NSAID) use, pa...
Purpose: To evaluate the prostate cancer (PCa) detection rate in men with chronic use of Aspirin and...
BACKGROUND: Despite strong laboratory evidence that non-steroidal anti-inflammatory drugs (NSAIDs) c...
Objective. To examine the association between daily use of nonsteroidal anti-inflammatory drugs (NSA...
Objectives: Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are potential candidate...
Epidemiologic studies of statin use in relation to prostate cancer risk have been inconclusive. Rece...
Background: There is substantial evidence that use of NSAIDs reduces the risk of colorectal cancer, ...
Background: Epidemiological evidences regarding the association between the use of non-steroidal ant...
International audienceChronic inflammation may play a role in prostate cancer carcinogenesis. In tha...
Despite strong laboratory evidence that non-steroidal anti-inflammatory drugs (NSAIDs) could prevent...
Background: Despite strong laboratory evidence that non-steroidal anti-inflammatory drugs (NSAIDs) c...
Background: Laboratory and epidemiologic studies suggest that aspirin and nonaspirin nonsteroidal an...
Evidence from laboratory studies suggests that chronic inflammation plays an important role in prost...
BackgroundAlthough most epidemiological studies suggest that non-steroidal anti-inflammatory drug us...
The potentially protective effect of nonsteroidal antiinflammatory drugs (NSAIDs) on prostate cancer...
Background: Randomized trial evidence shows that nonsteroidal anti-inflammatory drug (NSAID) use, pa...
Purpose: To evaluate the prostate cancer (PCa) detection rate in men with chronic use of Aspirin and...
BACKGROUND: Despite strong laboratory evidence that non-steroidal anti-inflammatory drugs (NSAIDs) c...
Objective. To examine the association between daily use of nonsteroidal anti-inflammatory drugs (NSA...
Objectives: Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are potential candidate...
Epidemiologic studies of statin use in relation to prostate cancer risk have been inconclusive. Rece...